reference/12682836

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12682836

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	132
issn	1755-5914 1755-5922
issueIdentifier	2
pageRange	124-132
publicationName	Cardiovascular Therapeutics
startingPage	124
bibliographicCitation	Krum H, McMurray JJV, Horton E, Gerlock T, Holzhauer B, Zuurman L, Haffner SM, Bethel MA, Holman RR, Califf RM. Baseline Characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial Population: Comparison with Other Diabetes Prevention Trials. Cardiovascular Therapeutics. 2010 Mar 05;28(2):124–32. doi: 10.1111/j.1755-5922.2010.00146.x.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d4ee25fa5e944a9227a3f1bac9d1e563 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c6931c8598a82fbf481e1f4a49da3ef1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_128a7c35d48b386416e1d65c3bba73c0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_acfc0ee1e9b5ec671b6ced4d85ba3edb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f185915337bfa81f2a8be96f6eeacf6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a6950d68d6fe8f3fbce0a613ab027f5d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d77365fef05fee2bbd77be037593284a http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9209-757X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a7ad2c796fbb918849737bc44219dff2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4b91171368ecb7927eb706fdd5a7a966 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e828d04eca93dcac367d4949cb356cf2
date	2010-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1111/j.1755-5922.2010.00146.x https://pubmed.ncbi.nlm.nih.gov/20184589
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/34512 https://portal.issn.org/resource/ISSN/1755-5922 https://portal.issn.org/resource/ISSN/1755-5914
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Baseline Characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial Population: Comparison with Other Diabetes Prevention Trials
discusses	http://id.nlm.nih.gov/mesh/M0217346 http://id.nlm.nih.gov/mesh/M0456879 http://id.nlm.nih.gov/mesh/M0016544 http://id.nlm.nih.gov/mesh/M0005469 http://id.nlm.nih.gov/mesh/M0353981 http://id.nlm.nih.gov/mesh/M0002696 http://id.nlm.nih.gov/mesh/M0021253 http://id.nlm.nih.gov/mesh/M0022497 http://id.nlm.nih.gov/mesh/M0010903
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D003510Q000627 http://id.nlm.nih.gov/mesh/D003920Q000517 http://id.nlm.nih.gov/mesh/D014633Q000031 http://id.nlm.nih.gov/mesh/D011236Q000188 http://id.nlm.nih.gov/mesh/D007004Q000627 http://id.nlm.nih.gov/mesh/D010649Q000031 http://id.nlm.nih.gov/mesh/D013777Q000627 http://id.nlm.nih.gov/mesh/D002318Q000517 http://id.nlm.nih.gov/mesh/D018149Q000188 http://id.nlm.nih.gov/mesh/D047228Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D002318Q000503 http://id.nlm.nih.gov/mesh/D012307 http://id.nlm.nih.gov/mesh/D003920Q000503 http://id.nlm.nih.gov/mesh/D003920Q000097 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D003920Q000209 http://id.nlm.nih.gov/mesh/D018570 http://id.nlm.nih.gov/mesh/D018579 http://id.nlm.nih.gov/mesh/D014633Q000627 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D011236Q000097 http://id.nlm.nih.gov/mesh/D012107 http://id.nlm.nih.gov/mesh/D010649Q000627 http://id.nlm.nih.gov/mesh/D001794 http://id.nlm.nih.gov/mesh/D000077715 http://id.nlm.nih.gov/mesh/D000068756 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D001786Q000378 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D018149Q000503 http://id.nlm.nih.gov/mesh/D002318Q000209 http://id.nlm.nih.gov/mesh/D018149Q000150 http://id.nlm.nih.gov/mesh/D018149Q000097 http://id.nlm.nih.gov/mesh/D011236Q000503 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D002318Q000097
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311309 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9ffa6b56d06ddd0c9bc50088955e425b http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_00559ea764f3549e2a9c714ecd8af73f http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8959 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9264 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10708 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5839 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460048 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7346 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10895 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60846 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10098 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8484 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102

Incoming Links

Predicate

Subject

http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128458032
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128121087
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129621433
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127654813
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128797137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127387957

Total number of triples: 102.